TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease: A Single Center, Randomized Pilot Study
Latest Information Update: 20 Feb 2024
At a glance
- Drugs Atomoxetine (Primary) ; Methylphenidate (Primary)
- Indications Neurologic gait disorders; Parkinson's disease
- Focus Therapeutic Use
- Acronyms TAME-PD
- 15 Feb 2024 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.
- 15 Feb 2024 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2025.
- 18 Jan 2023 Planned End Date changed from 1 Dec 2024 to 1 Dec 2025.